Board of Directors
Founder and Executive Director
Dr Fang-Xu Jiang is a medically-trained, world recognized stem cell biologist with extensive experience, expertise and skills in translational diabetes medicine in both Australia and China. He was an Associate Professor at the University of Western Australia and the founding head of the Islet Cell Development Program at the Harry Perkins Institute of Medical Research. Now he is dedicated to translating his lifelong research into real world therapies for diabetes.
Scientific & Clinical Advisory Team
Prof Wei Wang (Chair)
Professor Wei Wang is Pro-Vice-Chancellor (China) of Edith Cowan University (ECU), and a member of the expert panel advising the WHO on ‘Grand Challenges in Genomics for Public Health in Developing Countries’. He is also a steering committee member of the OECD initiative on Public Health Genomics. In 2017 Professor Wang was elected as a Fellow of the Royal Society of Medicine of United Kingdom. He has published over 200 scientific papers in prestigious journals including Science, Nature Genetics and The Lancet.
Dr Wei Wang
Dr Wei Wang is a Chief Physician, Professor, Head of Endocrinology Department at Xiang'an Hospital of Xiamen University, and a mentor for Master and Postdoctoral Research students. His research interests include: protective mechanism of islet beta cell function, metabolic spectrum characteristics of diabetes mellitus and mechanisms of chronic wound and diabetic foot. He has expertise in Endocrine Diseases, Diabetes, Hyperthyroidism and Diabetic foot.
Dr Fang-Xu Jiang (see above)